Acute Heart Failure (AHF) Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Acute Heart Failure (AHF) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure

Acute Heart Failure (AHF)Heart Failure (for Example, Fluid Overload)Heart Failure Hospitalization
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal1,014 enrolled25 locationsNCT07484009
Recruiting
Phase 4

Digoxin After Acute Heart Failure

Acute Heart Failure (AHF)
Guillermo Liniado120 enrolled1 locationNCT07321509
Recruiting
Not Applicable

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

Cardiogenic ShockCoronary Artery DiseaseChronic Heart Failure+4 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation100 enrolled1 locationNCT07149714
Recruiting
Not Applicable

Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure

Acute Heart Failure (AHF)Congestion, Venous
Wroclaw Medical University90 enrolled2 locationsNCT07099885
Recruiting
Not Applicable

Vietnamese Rapid Acceleration Protocol for Intensifying Drug Therapy in Heart Failure With Reduced Ejection Fraction

Acute Heart Failure (AHF)Acute Heart Failure With Reduced Ejection Fraction
University Medical Center Ho Chi Minh City (UMC)500 enrolled4 locationsNCT06595290
Recruiting

Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients

Congestive Heart Failure(CHF)Acute Heart Failure (AHF)
Consorci Sanitari Integral500 enrolled1 locationNCT06993220
Recruiting
Phase 2

Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure

Acute Heart Failure (AHF)
Aarhus University Hospital250 enrolled8 locationsNCT06653725